Hyperfine (HYPR) Competitors

Neuronetics (NASDAQ:STIM) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, community ranking, profitability, institutional ownership, earnings and valuation.

Does the media prefer STIM or HYPR?

In the previous week, Neuronetics and Neuronetics both had 2 articles in the media. Hyperfine's average media sentiment score of 1.32 beat Neuronetics' score of 0.94 indicating that Hyperfine is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hyperfine	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in STIM or HYPR?

53.6% of Neuronetics shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 8.7% of Neuronetics shares are held by insiders. Comparatively, 31.0% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has preferable valuation & earnings, STIM or HYPR?

Neuronetics has higher revenue and earnings than Hyperfine. Neuronetics is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$89.45M	2.80	-$30.19M	-$1.31	-2.91
Hyperfine	$11.73M	4.92	-$44.24M	-$0.54	-1.37

Is STIM or HYPR more profitable?

Neuronetics has a net margin of -50.09% compared to Hyperfine's net margin of -309.42%. Hyperfine's return on equity of -57.54% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-50.09%	-141.24%	-32.77%
Hyperfine	-309.42%	-57.54%	-50.38%

Which has more risk and volatility, STIM or HYPR?

Neuronetics has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Comparatively, Hyperfine has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.

Do analysts prefer STIM or HYPR?

Neuronetics currently has a consensus price target of $5.50, suggesting a potential upside of 44.36%. Hyperfine has a consensus price target of $1.06, suggesting a potential upside of 43.01%. Given Neuronetics' higher probable upside, research analysts clearly believe Neuronetics is more favorable than Hyperfine.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Hyperfine	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Does the MarketBeat Community favor STIM or HYPR?

Neuronetics received 121 more outperform votes than Hyperfine when rated by MarketBeat users. Likewise, 68.62% of users gave Neuronetics an outperform vote while only 50.00% of users gave Hyperfine an outperform vote.

Company	Underperform	Outperform
Neuronetics	Outperform Votes 129 68.62%	Underperform Votes 59 31.38%
Hyperfine	Outperform Votes 8 50.00%	Underperform Votes 8 50.00%

Summary

Neuronetics beats Hyperfine on 9 of the 15 factors compared between the two stocks.